Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,242 Jan 1 – Oct 28, 2026
- Disclosed funding
- $257.3B 1861 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| SI Synthpop, Inc.Company profile Builds agentic AI to automate administrative workflows in healthcare operations for payers providers and patients Builds agentic AI to automate administrative workflows in healthcare operations for payers providers and patients | $15M | Series A | Healthtech | United States | Investors | |
| BR Develops autonomous construction technology for general contractors | $270M | Series B | Proptech | United States | Investors | |
| E ElevenLabsCompany profile Develops voice AI models and audio synthesis tools for enterprise and consumer applications Develops voice AI models and audio synthesis tools for enterprise and consumer applications | $500M | Series DSeries C+ | AI | United States | Investors | |
Machina Labs uses AI and robotics in metal manufacturing. | $124M | Series CSeries C+ | Industrial tech | United States | Investors | |
Positron AICompany profile Positron AI develops memory-focused hardware and software for large-language-model inference. Positron AI develops memory-focused hardware and software for large-language-model inference. | $230M | Series B | AI | United States | Investors | |
| CC Chamber CardioCompany profile Enables cardiologists and health plans to manage heart disease patients under value-based care models Enables cardiologists and health plans to manage heart disease patients under value-based care models | $60M | Series A | Healthtech | United States | Investors | |
| RA Provides AI for running and operating software in production | $125M | Series A | AI | United States | Investors | |
| TA Third Arc BioCompany profile Develops novel multifunctional antibodies for oncology and immunology & inflammation indications Develops novel multifunctional antibodies for oncology and immunology & inflammation indications | $52M | Series A+Series A | Biotech | United States | Investors | |
Evergreen SelectCompany profile Produces cultivated beef for integration into existing food-production systems. Produces cultivated beef for integration into existing food-production systems. | $6M | Undisclosed | Foodtech | United States | Investors | |
| S Builds Collaborative Intelligence platform for enterprises | $100M | Growth | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
133rounds3led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
100rounds20led - 3General Catalyst
Hyperbolic, Re:Build, Provision Labs
73rounds8led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
59rounds0led - 5Sequoia Capital
Hex, Warhound, Whop
58rounds9led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.